Olema Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Olema Pharmaceuticals Inc cash flow-to-debt ratio. Olema Pharmaceuticals Inc (OLMA) has a Cash Flow-to-Debt Ratio of -0.92x as of March 2026, meaning its operating cash flow of $-45.99 Million could theoretically repay -1% of its total liabilities ($50.17 Million) in one year. See how financially flexible is Olema Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Olema Pharmaceuticals Inc (2018–2025)
Cash flow-to-debt ratio of Olema Pharmaceuticals Inc from 2018 to 2025. Historical debt coverage capacity for Olema Pharmaceuticals Inc across 8 annual periods. Also explore OLMA net assets growth trend to track the company's year-over-year net asset growth rate.
Olema Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Olema Pharmaceuticals Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Olema Pharmaceuticals Inc. For the full cash flow conversion analysis, see Olema Pharmaceuticals Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.67x | $-146.72 Million | $54.87 Million | ▼ -7.7% |
| 2024 | -2.48x | $-104.35 Million | $42.02 Million | ▲ +31.6% |
| 2023 | -3.63x | $-83.73 Million | $23.05 Million | ▲ +19.9% |
| 2022 | -4.53x | $-82.06 Million | $18.10 Million | ▼ -1.8% |
| 2021 | -4.46x | $-50.69 Million | $11.38 Million | ▼ -2.8% |
| 2020 | -4.33x | $-19.87 Million | $4.58 Million | ▼ -1408.4% |
| 2019 | -0.29x | $-3.08 Million | $10.73 Million | ▼ -26.1% |
| 2018 | -0.23x | $-2.18 Million | $9.55 Million | — |